Advertisement

Index by author

July 01, 1982; Volume 22,Issue 1

A

  1. Adler, A

    1. Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring.
      L W Scheibel and A Adler
      Molecular Pharmacology July 1982, 22 (1) 140-144;

  2. Affolter, H

    1. Storage of biogenic amines in intact blood platelets of man. Dependence on a proton gradient.
      H Affolter and A Pletscher
      Molecular Pharmacology July 1982, 22 (1) 94-98;

  3. Albuquerque, E X

    1. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque, N Bakry, A T Eldefrawi and E X Albuquerque
      Molecular Pharmacology July 1982, 22 (1) 82-93;

  4. Alvares, A P

    1. Pulmonary cytochromes P-450 from rabbits treated with 3-methylcholanthrene.
      T H Ueng and A P Alvares
      Molecular Pharmacology July 1982, 22 (1) 221-228;

  5. Asao, Y

    1. A possible mechanism for elevation of glucose-6-phosphatase activity in kidney and liver of fluoride-treated rats.
      Y Suketa, M Yamada, J Hasegawa and Y Asao
      Molecular Pharmacology July 1982, 22 (1) 116-120;

B

  1. Bakry, N

    1. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque, N Bakry, A T Eldefrawi and E X Albuquerque
      Molecular Pharmacology July 1982, 22 (1) 82-93;

  2. Bakry, N M

    1. Interactions of quaternary ammonium drugs with acetylcholinesterase and acetylcholine receptor of Torpedo electric organ.
      N M Bakry, A T Eldefrawi, M E Eldefrawi and W F Riker
      Molecular Pharmacology July 1982, 22 (1) 63-71;

  3. Batzri, S

    1. Interaction of histamine with gastric mucosal cells. Effect of histamine agonists on binding and biological response.
      S Batzri, J W Harmon and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 33-40;
    2. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
      S Batzri, J W Harmon, J Dyer and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 41-47;

  4. Beaujouan, J C

    1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
      J C Beaujouan, Y Torrens, A Herbet, M C Daguet, J Glowinski and A Prochiantz
      Molecular Pharmacology July 1982, 22 (1) 48-55;

  5. Beiderman, B

    1. Three adenylate cyclase phenotypes in S49 lymphoma cells produced by mutations of one gene.
      H R Bourne, B Beiderman, F Steinberg and V M Brothers
      Molecular Pharmacology July 1982, 22 (1) 204-210;

  6. Boulenger, J P

    1. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864.
      P J Marangos, J Patel, J P Boulenger and R Clark-Rosenberg
      Molecular Pharmacology July 1982, 22 (1) 26-32;

  7. Bourne, H R

    1. Three adenylate cyclase phenotypes in S49 lymphoma cells produced by mutations of one gene.
      H R Bourne, B Beiderman, F Steinberg and V M Brothers
      Molecular Pharmacology July 1982, 22 (1) 204-210;

  8. Brothers, V M

    1. Three adenylate cyclase phenotypes in S49 lymphoma cells produced by mutations of one gene.
      H R Bourne, B Beiderman, F Steinberg and V M Brothers
      Molecular Pharmacology July 1982, 22 (1) 204-210;

C

  1. Catterall, W A

    1. Characterization of variant neuroblastoma clones with missing or altered sodium channels.
      M R Costa and W A Catterall
      Molecular Pharmacology July 1982, 22 (1) 196-203;

  2. Clark-Rosenberg, R

    1. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864.
      P J Marangos, J Patel, J P Boulenger and R Clark-Rosenberg
      Molecular Pharmacology July 1982, 22 (1) 26-32;

  3. Conney, A H

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;

  4. Costa, M R

    1. Characterization of variant neuroblastoma clones with missing or altered sodium channels.
      M R Costa and W A Catterall
      Molecular Pharmacology July 1982, 22 (1) 196-203;

  5. Crippen, G M

    1. Distance geometry analysis of the benzodiazepine binding site.
      G M Crippen
      Molecular Pharmacology July 1982, 22 (1) 11-19;

  6. Crooke, S T

    1. Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells.
      B H Long, C E Willis, A W Prestayko and S T Crooke
      Molecular Pharmacology July 1982, 22 (1) 152-157;

D

  1. Daguet, M C

    1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
      J C Beaujouan, Y Torrens, A Herbet, M C Daguet, J Glowinski and A Prochiantz
      Molecular Pharmacology July 1982, 22 (1) 48-55;

  2. Dalmark, M

    1. Molecular association between doxorubicin (adriamycin) and DNA-derived bases, nucleosides, nucleotides, other aromatic compounds, and proteins in aqueous solution.
      M Dalmark and P Johansen
      Molecular Pharmacology July 1982, 22 (1) 158-165;

  3. Dax, E M

    1. Adrenergic ligand liposolubility in membranes. Direct assessment in a beta-adrenergic binding system.
      E M Dax and J S Partilla
      Molecular Pharmacology July 1982, 22 (1) 5-7;

  4. Diaham, B

    1. Methylmercury(II)-induced histone perturbations in nuclei isolated from calf thymus.
      D W Gruenwedel and B Diaham
      Molecular Pharmacology July 1982, 22 (1) 121-126;

  5. Dyer, J

    1. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
      S Batzri, J W Harmon, J Dyer and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 41-47;

E

  1. Eldefrawi, A T

    1. Interactions of quaternary ammonium drugs with acetylcholinesterase and acetylcholine receptor of Torpedo electric organ.
      N M Bakry, A T Eldefrawi, M E Eldefrawi and W F Riker
      Molecular Pharmacology July 1982, 22 (1) 63-71;
    2. [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs.
      A T Eldefrawi, E R Miller, D L Murphy and M E Eldefrawi
      Molecular Pharmacology July 1982, 22 (1) 72-81;
    3. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque, N Bakry, A T Eldefrawi and E X Albuquerque
      Molecular Pharmacology July 1982, 22 (1) 82-93;

  2. Eldefrawi, M E

    1. Interactions of quaternary ammonium drugs with acetylcholinesterase and acetylcholine receptor of Torpedo electric organ.
      N M Bakry, A T Eldefrawi, M E Eldefrawi and W F Riker
      Molecular Pharmacology July 1982, 22 (1) 63-71;
    2. [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs.
      A T Eldefrawi, E R Miller, D L Murphy and M E Eldefrawi
      Molecular Pharmacology July 1982, 22 (1) 72-81;

  3. Epand, R M

    1. Cation-induced conformational change in glucagon.
      R M Epand
      Molecular Pharmacology July 1982, 22 (1) 105-108;

  4. Erickson, L C

    1. The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
      L M Ramonas, L C Erickson and M E McManus
      Molecular Pharmacology July 1982, 22 (1) 175-181;

F

  1. Fain, J N

    1. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
      I Litosch, T H Hudson, I Mills, S Y Li and J N Fain
      Molecular Pharmacology July 1982, 22 (1) 109-115;

G

  1. Glaumann, H

    1. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity.
      P E Thomas, D E Ryan, C von Bahr, H Glaumann and W Levin
      Molecular Pharmacology July 1982, 22 (1) 190-195;

  2. Glowinski, J

    1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
      J C Beaujouan, Y Torrens, A Herbet, M C Daguet, J Glowinski and A Prochiantz
      Molecular Pharmacology July 1982, 22 (1) 48-55;

  3. Gruenwedel, D W

    1. Methylmercury(II)-induced histone perturbations in nuclei isolated from calf thymus.
      D W Gruenwedel and B Diaham
      Molecular Pharmacology July 1982, 22 (1) 121-126;

  4. Grunewald, G L

    1. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
      M F Rafferty and G L Grunewald
      Molecular Pharmacology July 1982, 22 (1) 127-132;

H

  1. Harmon, J W

    1. Interaction of histamine with gastric mucosal cells. Effect of histamine agonists on binding and biological response.
      S Batzri, J W Harmon and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 33-40;
    2. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
      S Batzri, J W Harmon, J Dyer and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 41-47;

  2. Harris, R A

    1. Alcohols and synaptosomal calcium transport.
      J A Stokes and R A Harris
      Molecular Pharmacology July 1982, 22 (1) 99-104;

  3. Hasegawa, J

    1. A possible mechanism for elevation of glucose-6-phosphatase activity in kidney and liver of fluoride-treated rats.
      Y Suketa, M Yamada, J Hasegawa and Y Asao
      Molecular Pharmacology July 1982, 22 (1) 116-120;

  4. Herbet, A

    1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
      J C Beaujouan, Y Torrens, A Herbet, M C Daguet, J Glowinski and A Prochiantz
      Molecular Pharmacology July 1982, 22 (1) 48-55;

  5. Hom, D S

    1. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process.
      P Y Law, D S Hom and H H Loh
      Molecular Pharmacology July 1982, 22 (1) 1-4;

  6. Hudson, T H

    1. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
      I Litosch, T H Hudson, I Mills, S Y Li and J N Fain
      Molecular Pharmacology July 1982, 22 (1) 109-115;

J

  1. Jerina, D M

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;

  2. Johansen, P

    1. Molecular association between doxorubicin (adriamycin) and DNA-derived bases, nucleosides, nucleotides, other aromatic compounds, and proteins in aqueous solution.
      M Dalmark and P Johansen
      Molecular Pharmacology July 1982, 22 (1) 158-165;

K

  1. Kanter, P M

    1. A fluorescence enhancement assay for cellular DNA damage.
      P M Kanter and H S Schwartz
      Molecular Pharmacology July 1982, 22 (1) 145-151;

  2. Kellar, K J

    1. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
      R D Schwartz, R McGee and K J Kellar
      Molecular Pharmacology July 1982, 22 (1) 56-62;

L

  1. Law, P Y

    1. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process.
      P Y Law, D S Hom and H H Loh
      Molecular Pharmacology July 1982, 22 (1) 1-4;

  2. Levin, W

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;
    2. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity.
      P E Thomas, D E Ryan, C von Bahr, H Glaumann and W Levin
      Molecular Pharmacology July 1982, 22 (1) 190-195;

  3. Li, S Y

    1. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
      I Litosch, T H Hudson, I Mills, S Y Li and J N Fain
      Molecular Pharmacology July 1982, 22 (1) 109-115;

  4. Litosch, I

    1. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
      I Litosch, T H Hudson, I Mills, S Y Li and J N Fain
      Molecular Pharmacology July 1982, 22 (1) 109-115;

  5. Loh, H H

    1. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process.
      P Y Law, D S Hom and H H Loh
      Molecular Pharmacology July 1982, 22 (1) 1-4;

  6. Long, B H

    1. Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells.
      B H Long, C E Willis, A W Prestayko and S T Crooke
      Molecular Pharmacology July 1982, 22 (1) 152-157;

M

  1. Mählmann, H

    1. Temperature dependence of the benzodiazepine-receptor interaction.
      U Quast, H Mählmann and K O Vollmer
      Molecular Pharmacology July 1982, 22 (1) 20-25;

  2. Maleque, M A

    1. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque, N Bakry, A T Eldefrawi and E X Albuquerque
      Molecular Pharmacology July 1982, 22 (1) 82-93;

  3. Malinconico, S M

    1. Effect of halothane on cardiac sarcoplasmic reticulum Ca2+-ATPase at low calcium concentrations.
      S M Malinconico and R L McCarl
      Molecular Pharmacology July 1982, 22 (1) 8-10;

  4. Marangos, P J

    1. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864.
      P J Marangos, J Patel, J P Boulenger and R Clark-Rosenberg
      Molecular Pharmacology July 1982, 22 (1) 26-32;

  5. Maren, T H

    1. The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions.
      G Sanyal, E R Swenson, N I Pessah and T H Maren
      Molecular Pharmacology July 1982, 22 (1) 211-220;

  6. McCarl, R L

    1. Effect of halothane on cardiac sarcoplasmic reticulum Ca2+-ATPase at low calcium concentrations.
      S M Malinconico and R L McCarl
      Molecular Pharmacology July 1982, 22 (1) 8-10;

  7. McGee, R

    1. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
      R D Schwartz, R McGee and K J Kellar
      Molecular Pharmacology July 1982, 22 (1) 56-62;

  8. McManus, M E

    1. The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
      L M Ramonas, L C Erickson and M E McManus
      Molecular Pharmacology July 1982, 22 (1) 175-181;

  9. Miller, E R

    1. [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs.
      A T Eldefrawi, E R Miller, D L Murphy and M E Eldefrawi
      Molecular Pharmacology July 1982, 22 (1) 72-81;

  10. Mills, I

    1. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
      I Litosch, T H Hudson, I Mills, S Y Li and J N Fain
      Molecular Pharmacology July 1982, 22 (1) 109-115;

  11. Murphy, D L

    1. [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs.
      A T Eldefrawi, E R Miller, D L Murphy and M E Eldefrawi
      Molecular Pharmacology July 1982, 22 (1) 72-81;

P

  1. Partilla, J S

    1. Adrenergic ligand liposolubility in membranes. Direct assessment in a beta-adrenergic binding system.
      E M Dax and J S Partilla
      Molecular Pharmacology July 1982, 22 (1) 5-7;

  2. Patel, J

    1. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864.
      P J Marangos, J Patel, J P Boulenger and R Clark-Rosenberg
      Molecular Pharmacology July 1982, 22 (1) 26-32;

  3. Perez, D J

    1. The metabolic basis of deoxyuridine cytotoxicity. Studies of cultured human lymphoblasts.
      D J Perez and M H Tattersall
      Molecular Pharmacology July 1982, 22 (1) 166-174;

  4. Pessah, N I

    1. The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions.
      G Sanyal, E R Swenson, N I Pessah and T H Maren
      Molecular Pharmacology July 1982, 22 (1) 211-220;

  5. Pletscher, A

    1. Storage of biogenic amines in intact blood platelets of man. Dependence on a proton gradient.
      H Affolter and A Pletscher
      Molecular Pharmacology July 1982, 22 (1) 94-98;

  6. Prestayko, A W

    1. Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells.
      B H Long, C E Willis, A W Prestayko and S T Crooke
      Molecular Pharmacology July 1982, 22 (1) 152-157;

  7. Prochiantz, A

    1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
      J C Beaujouan, Y Torrens, A Herbet, M C Daguet, J Glowinski and A Prochiantz
      Molecular Pharmacology July 1982, 22 (1) 48-55;

Q

  1. Quast, U

    1. Temperature dependence of the benzodiazepine-receptor interaction.
      U Quast, H Mählmann and K O Vollmer
      Molecular Pharmacology July 1982, 22 (1) 20-25;

R

  1. Rafferty, M F

    1. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
      M F Rafferty and G L Grunewald
      Molecular Pharmacology July 1982, 22 (1) 127-132;

  2. Ramonas, L M

    1. The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells.
      L M Ramonas, L C Erickson and M E McManus
      Molecular Pharmacology July 1982, 22 (1) 175-181;

  3. Riker, W F

    1. Interactions of quaternary ammonium drugs with acetylcholinesterase and acetylcholine receptor of Torpedo electric organ.
      N M Bakry, A T Eldefrawi, M E Eldefrawi and W F Riker
      Molecular Pharmacology July 1982, 22 (1) 63-71;

  4. Rowe, E S

    1. The effects of ethanol on the thermotropic properties of dipalmitoylphosphatidylcholine.
      E S Rowe
      Molecular Pharmacology July 1982, 22 (1) 133-139;

  5. Ryan, D E

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;
    2. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity.
      P E Thomas, D E Ryan, C von Bahr, H Glaumann and W Levin
      Molecular Pharmacology July 1982, 22 (1) 190-195;

S

  1. Sanyal, G

    1. The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions.
      G Sanyal, E R Swenson, N I Pessah and T H Maren
      Molecular Pharmacology July 1982, 22 (1) 211-220;

  2. Scheibel, L W

    1. Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring.
      L W Scheibel and A Adler
      Molecular Pharmacology July 1982, 22 (1) 140-144;

  3. Schwartz, H S

    1. A fluorescence enhancement assay for cellular DNA damage.
      P M Kanter and H S Schwartz
      Molecular Pharmacology July 1982, 22 (1) 145-151;

  4. Schwartz, R D

    1. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
      R D Schwartz, R McGee and K J Kellar
      Molecular Pharmacology July 1982, 22 (1) 56-62;

  5. Steinberg, F

    1. Three adenylate cyclase phenotypes in S49 lymphoma cells produced by mutations of one gene.
      H R Bourne, B Beiderman, F Steinberg and V M Brothers
      Molecular Pharmacology July 1982, 22 (1) 204-210;

  6. Stokes, J A

    1. Alcohols and synaptosomal calcium transport.
      J A Stokes and R A Harris
      Molecular Pharmacology July 1982, 22 (1) 99-104;

  7. Suketa, Y

    1. A possible mechanism for elevation of glucose-6-phosphatase activity in kidney and liver of fluoride-treated rats.
      Y Suketa, M Yamada, J Hasegawa and Y Asao
      Molecular Pharmacology July 1982, 22 (1) 116-120;

  8. Swenson, E R

    1. The carbon dioxide hydration activity of skeletal muscle carbonic anhydrase. Inhibition by sulfonamides and anions.
      G Sanyal, E R Swenson, N I Pessah and T H Maren
      Molecular Pharmacology July 1982, 22 (1) 211-220;

T

  1. Tattersall, M H

    1. The metabolic basis of deoxyuridine cytotoxicity. Studies of cultured human lymphoblasts.
      D J Perez and M H Tattersall
      Molecular Pharmacology July 1982, 22 (1) 166-174;

  2. Thakker, D R

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;

  3. Thomas, P E

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;
    2. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity.
      P E Thomas, D E Ryan, C von Bahr, H Glaumann and W Levin
      Molecular Pharmacology July 1982, 22 (1) 190-195;

  4. Thompson, W F

    1. Interaction of histamine with gastric mucosal cells. Effect of histamine agonists on binding and biological response.
      S Batzri, J W Harmon and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 33-40;
    2. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
      S Batzri, J W Harmon, J Dyer and W F Thompson
      Molecular Pharmacology July 1982, 22 (1) 41-47;

  5. Torrens, Y

    1. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
      J C Beaujouan, Y Torrens, A Herbet, M C Daguet, J Glowinski and A Prochiantz
      Molecular Pharmacology July 1982, 22 (1) 48-55;

U

  1. Ueng, T H

    1. Pulmonary cytochromes P-450 from rabbits treated with 3-methylcholanthrene.
      T H Ueng and A P Alvares
      Molecular Pharmacology July 1982, 22 (1) 221-228;

V

  1. Vollmer, K O

    1. Temperature dependence of the benzodiazepine-receptor interaction.
      U Quast, H Mählmann and K O Vollmer
      Molecular Pharmacology July 1982, 22 (1) 20-25;

  2. von Bahr, C

    1. Human liver microsomal epoxide hydrolase. Correlation of immunochemical quantitation with catalytic activity.
      P E Thomas, D E Ryan, C von Bahr, H Glaumann and W Levin
      Molecular Pharmacology July 1982, 22 (1) 190-195;

  3. Vyas, K P

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;

W

  1. Warnick, J E

    1. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
      J E Warnick, M A Maleque, N Bakry, A T Eldefrawi and E X Albuquerque
      Molecular Pharmacology July 1982, 22 (1) 82-93;

  2. Willis, C E

    1. Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells.
      B H Long, C E Willis, A W Prestayko and S T Crooke
      Molecular Pharmacology July 1982, 22 (1) 152-157;

Y

  1. Yagi, H

    1. Stereoselective metabolism of the (+)- and (-)-enantiomers of trans-1,2-dihydroxy-1,2-dihydrochrysene to bay-region 1,2-diol-3,4-epoxide diastereomers by rat liver enzymes.
      K P Vyas, W Levin, H Yagi, D R Thakker, D E Ryan, P E Thomas, A H Conney and D M Jerina
      Molecular Pharmacology July 1982, 22 (1) 182-189;

  2. Yamada, M

    1. A possible mechanism for elevation of glucose-6-phosphatase activity in kidney and liver of fluoride-treated rats.
      Y Suketa, M Yamada, J Hasegawa and Y Asao
      Molecular Pharmacology July 1982, 22 (1) 116-120;
Back to top

In this issue